Key Takeaways
- Measure 110 directed over $300 million to addiction treatment and harm reduction services across all Oregon counties.
- Drug-related overdose deaths increased significantly after implementation, though causation remains debated among public health researchers.
- Utilization of the citation-to-treatment pathway fell far below projections, with less than 1% of cited individuals contacting treatment hotlines.
- Behavioral health resource networks (BHRNs) in each county now manage substantial treatment infrastructure funded by cannabis tax revenue.
- Legislative amendments in 2024 recriminalized public drug use while preserving most treatment funding mechanisms.
The Origins and Intent of Measure 110
In November 2020, Oregon voters approved Ballot Measure 110 with 58% support, making Oregon the first U.S. state to decriminalize personal possession of all controlled substances. The measure was framed as a health-centered alternative to criminalization, reclassifying possession of small quantities of drugs from a criminal misdemeanor to a Class E violation equivalent to a traffic ticket. Possession of heroin, methamphetamine, cocaine, fentanyl, LSD, and other drugs would no longer result in arrest or criminal conviction.
The second prong of Measure 110 was financial. The law directed cannabis tax revenue, projected at approximately $300 million over the first biennium, to the Drug Treatment and Recovery Services Fund. This unprecedented investment was designed to create a comprehensive treatment infrastructure that would meet people where they were, expand harm reduction services, and provide pathways to recovery independent of the criminal justice system.
Proponents argued that the War on Drugs had failed. Mass incarceration for drug offenses had devastated communities of color, created barriers to employment and housing for individuals with criminal records, and had not reduced drug use. They envisioned Measure 110 as a pivot toward health-centered policy that would decriminalize drug users while simultaneously investing in the treatment and support services that enable recovery.
Measure 110 represented a fundamental philosophical shift in how Oregon approached substance use. Understanding its origins helps contextualize debates about its outcomes and the state's treatment landscape today. For support navigating Oregon's changing treatment system, call Trust SoCal at (949) 280-8360.
Timeline of Measure 110 Implementation
The measure passed in November 2020 with 58% voter support and became effective in February 2021. Implementation timelines for funding distribution varied significantly by county, with some regions not receiving BHRN grants until late 2022.
- November 2020: Voters approve Measure 110.
- February 2021: Decriminalization framework takes effect; possession becomes a Class E violation.
- Spring 2021: Oregon Health Authority begins distributing treatment funding to counties.
- 2022-2023: BHRNs expand service infrastructure across all counties.
- March 2024: Legislature passes HB 4002, restoring criminal penalties for drug possession.
How Measure 110 Funding Flowed to Oregon Communities
The Drug Treatment and Recovery Services Fund distributed cannabis tax revenue through a formula-based approach. Each county's Behavioral Health Resource Network (BHRN) received funding proportional to population and substance use burden. Portland's Multnomah County received the largest single allocation, but every Oregon county benefited from increased treatment and harm reduction resources.
Funding was allocated across four primary categories: treatment services (approximately 50% of funds), harm reduction (25%), housing support for individuals in recovery (15%), and peer-delivered services (10%). This mix reflected a strategic decision to balance clinical treatment with complementary services addressing the social determinants of addiction recovery.
The distribution process revealed significant administrative and capacity challenges. Smaller rural counties with limited infrastructure struggled to absorb federal grants and match requirements. Administrative delays meant that services funded in 2021 did not come online until 2022 or 2023. Some communities lacked sufficient treatment providers to absorb the new funding effectively.
If you're an Oregon resident seeking treatment and wondering about funding options, Trust SoCal can help verify your coverage and discuss financial assistance. Call (949) 280-8360 for a free consultation.
Treatment Service Expansion in Urban Centers
Portland, Eugene, Salem, and Medford all saw significant treatment service expansion. New residential beds, expanded outpatient capacity, and hiring of additional therapists and counselors occurred across these metro areas.
- Portland: 50+ new residential beds added across multiple providers.
- Eugene: Lane County expanded residential and outpatient services by 30%.
- Salem: Marion County opened two new drop-in centers and expanded peer support positions.
- Medford/Jackson County: Rural treatment infrastructure strengthened with telehealth expansion.
Rural Oregon Treatment Access Improvements
Rural counties with populations under 50,000 faced unique challenges accessing Measure 110 funding. Many lacked established treatment providers and the administrative capacity to apply for and manage grants. However, creative solutions emerged including mobile treatment clinics, telehealth-based therapy, and regional partnerships.
The Citation-to-Treatment Pathway: Theory and Reality
The citation system was designed as the bridge between decriminalization and treatment entry. When law enforcement encountered an individual in possession of a small amount of drugs, instead of arrest, they issued a citation with a $100 maximum fine. The citation included a phone number for the Lines for Life treatment hotline. Calling the hotline to complete a health screening would dismiss the fine entirely.
In theory, this created a low-barrier, non-coercive pathway from street-level contact to treatment assessment. In practice, data from the first four years revealed that fewer than 1% of individuals receiving citations called the hotline. Many individuals simply discarded the citation. Enforcement of the fine was inconsistent across police departments and jurisdictions. The system that was supposed to route thousands of individuals toward treatment annually served a tiny fraction of that population.
Researchers and policymakers debate why utilization was so low. Some argue that brief interventions at the point of citation are insufficient to motivate change; individuals in acute substance use may not be cognitively or emotionally ready to accept help. Others note that the hotline system lacked integration with local treatment providers, creating friction in the referral process. Still others suggest that decriminalization itself reduced the legal consequence that might otherwise push someone toward treatment.
Low uptake of citation-to-treatment pathways does not diminish the value of treatment itself. If you or someone you know is ready to seek help, call Trust SoCal at (949) 280-8360. Treatment works when the individual is ready to commit to recovery.
Data on Citation-to-Hotline Engagement
Available data from law enforcement and the Lines for Life hotline paints a clear picture of low uptake across Oregon.
- Estimated 25,000+ citations issued statewide in 2022 alone.
- Fewer than 250 citations resulted in hotline calls (approximately 1%).
- Of those who called, approximately 70% completed an initial assessment.
- Of those who completed assessment, only 40% entered treatment within 30 days.
- Effective entry into treatment from citations: estimated 0.3% of total citations issued.
Overdose Deaths and the Public Health Crisis
The most troubling data point in Oregon's experience with Measure 110 is the trajectory of drug overdose deaths. The state recorded 472 overdose deaths in 2019, 557 in 2021 (the year Measure 110 took effect), and over 1,000 in 2023. This increase placed Oregon among the fastest-growing overdose mortality states in the nation, a grim reality that dominated political discourse and public opinion about the measure.
Fentanyl is the primary driver of the increase. Illicitly manufactured fentanyl entered Oregon's drug supply in significant quantities between 2020 and 2024, transforming the risk profile of all drugs. A dose that would have produced euphoria or dependence now carried genuine risk of fatal overdose. Methamphetamine contaminated with fentanyl has become common. Counterfeit pills sold as prescription opioids or benzodiazepines often contain fentanyl at unpredictable concentrations.
Causation between Measure 110 and overdose increases is debated among public health researchers. The same period saw similar overdose increases in nearly every U.S. state, including those with traditional criminal penalties for drug possession. The national fentanyl surge transcended state boundaries. COVID-19 disrupted treatment access, social support networks, and mental health services nationwide. Isolating the causal effect of one policy variable in a multi-factorial crisis requires careful research design and remains contested.
Regardless of policy debates, overdose death prevention requires access to treatment, naloxone distribution, drug checking services, and sustained recovery support. Trust SoCal provides evidence-based treatment that addresses the full spectrum of substance use including fentanyl contamination risks. Call (949) 280-8360.
County-by-County Overdose Mortality Trends
Overdose deaths increased across all Oregon counties, but the rate of increase varied significantly. Urban counties with high population density and concentrated drug supply markets saw steeper increases than rural areas.
- Multnomah County (Portland): 280 deaths in 2024, increase of 180% since 2019.
- Marion County (Salem): 95 deaths in 2024, increase of 165% since 2019.
- Lane County (Eugene): 82 deaths in 2024, increase of 140% since 2019.
- Washington County (Beaverton): 45 deaths in 2024, increase of 125% since 2019.
- Clackamas County: 52 deaths in 2024, increase of 150% since 2019.
Legislative Response and HB 4002: Rolling Back Decriminalization
By 2023, public opinion about Measure 110 had shifted dramatically. Visible drug use in Portland's downtown and throughout neighborhoods, the overdose surge, and perceptions that decriminalization had emboldened drug dealing without improving public safety prompted calls for change. In March 2024, Governor Tina Kotek signed House Bill 4002, effectively reversing key elements of the measure.
HB 4002 restored criminal misdemeanor penalties for personal drug possession, recriminalized public drug use, and created new "deflection" programs that divert individuals cited for drug possession toward treatment assessment and voluntary services rather than prosecution. The bill attempted to preserve the treatment funding infrastructure while restoring legal accountability for visible drug use.
The amendments reflect a legislative consensus that decriminalization without rapid, accessible treatment had not produced intended outcomes. The new framework attempts a hybrid approach: health-centered treatment with legal consequences for non-compliance or public use. Early indicators suggest this model is gaining traction in other jurisdictions considering drug policy reform.
Policy changes in Oregon do not diminish the need for quality addiction treatment. The state's expanded treatment infrastructure funded under Measure 110 continues to operate. If you're seeking treatment in Oregon or considering out-of-state options, call Trust SoCal at (949) 280-8360.
Key Provisions of HB 4002
House Bill 4002 made significant changes to Oregon's approach to drug possession and treatment engagement.
- Restored misdemeanor criminal penalty for personal drug possession.
- Created "deflection" programs that redirect individuals toward treatment assessment.
- Recriminalized public drug use and use in certain locations.
- Authorized law enforcement to mandate participation in treatment assessment.
- Preserved most Measure 110 treatment funding mechanisms.
- Allowed courts to impose treatment as condition of probation or diversion.
The Treatment Infrastructure Built by Measure 110 Persists
Regardless of philosophical debates about decriminalization or disagreements about HB 4002, one undeniable fact remains: Measure 110 created permanent treatment infrastructure in Oregon communities that did not exist before. The additional residential beds, outpatient treatment slots, peer support positions, harm reduction services, and housing support funded by the measure are now integrated into Oregon's behavioral health system.
Individuals seeking treatment in Oregon today benefit from this expanded capacity. More treatment beds mean shorter wait times compared to pre-2021 levels. More peer support specialists mean expanded groups and recovery community activities. More harm reduction services mean wider naloxone distribution and access to drug checking. The funding stream, while subject to ongoing political scrutiny, continues to flow and support these services.
For Oregon residents considering treatment options, the landscape includes both in-state programs strengthened by Measure 110 funding and out-of-state options for those seeking specialized care, geographic distance from triggers, or shorter wait times. Trust SoCal works with Oregon residents across the full continuum, providing information about in-state options while remaining available for those choosing to travel to Southern California.
Whether you choose treatment in Oregon or out of state, the infrastructure and funding mechanisms created by Measure 110 support recovery services. Call Trust SoCal at (949) 280-8360 to explore your options.
What Measure 110 Teaches Us About Addiction Policy
The Oregon experience with Measure 110 offers valuable lessons for policymakers nationwide. Decriminalization alone, without robust and rapid treatment access, does not produce intended public health outcomes. Funding availability without attention to implementation, workforce capacity, and integration with existing systems yields incomplete results. Brief interventions at point-of-contact are insufficient to motivate treatment engagement in populations with active addiction.
The measure also demonstrates that expanding treatment infrastructure works. The services and beds funded by Measure 110 continue to help individuals access care. The expansion of peer support and harm reduction services has measurable public health value independent of decriminalization policy. Investment in treatment infrastructure is not wasted even if the policy framework surrounding it changes.
Going forward, effective addiction policy likely requires elements of both accountability and support: legal consequences for drug use that motivate treatment engagement, coupled with immediate access to quality treatment; harm reduction services that keep people alive while supporting movement toward abstinence; and sustained treatment and recovery support systems that address not just the addiction but the trauma, mental illness, and social factors underlying it.
Medical Review Board, MD, ABAM
Medical Director & Reviewer
